Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May;55(3):188-94.
doi: 10.4103/0300-1652.132035.

Ethics of clinical trials in Nigeria

Patrick I Okonta  1
Affiliations

Ethics of clinical trials in Nigeria

Patrick I Okonta. Niger Med J. 2014 May.

Abstract

The conduct of clinical trials for the development and licensing of drugs is a very important aspect of healthcare. Drug research, development and promotion have grown to a multi-billion dollar global business. Like all areas of human endeavour involving generation and control of huge financial resources, it could be subject to deviant behaviour, sharp business practices and unethical practices. The main objective of this review is to highlight potential ethical challenges in the conduct of clinical trials in Nigeria and outline ways in which these can be avoided. Current international and national regulatory and ethical guidelines are reviewed to illustrate the requirements for ethical conduct of clinical trials. Past experiences of unethical conduct of clinical trials especially in developing countries along with the increasing globalisation of research makes it imperative that all players should be aware of the ethical challenges in clinical trials and the benchmarks for ethical conduct of clinical research in Nigeria.

Keywords: Clinical trials; Nigeria; ethics.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Steven S. Pharmaceutical market trends, 2010 - 2014: Key market forecasts and growth opportunities. 4th ed. London: Urch Publishing; 2010. p. 142.
    1. Pharma 2020: The vision- Which path will you take? London: PricewaterhouseCoopers; 2007. p. 52.
    1. Zidovudine for mother, fetus, and child: Hope or poison? Lancet. 1994;344:207–9. - PubMed
    1. Lurie P, Wolfe SM. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med. 1997;337:853–6. - PubMed
    1. Merson MH. Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World. N Engl J Med. 1998;338:836. - PubMed

LinkOut - more resources